J.‐P. Magaud - Concepedia

Author

J.‐P. Magaud

Hôpital Edouard Herriot

Also Known As

J P Magaud, J. P. Magaud, J.-P. Magaud, J.P. Magaud, J.‐P. Magaud, JEAN PIERRE MAGAUD, Jean Pierre Magaud

Publications

Citations

H-Index

Concepts

All Affiliations

Hôpital Edouard Herriot Inserm Centre Léon Bérard John Radcliffe Hospital

About

J.‐P. Magaud is an author at Hôpital Edouard Herriot specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	725
2	Cell Biology	4	4	340
3	Immunology	4	4	362
4	Allergy	2	2	245
5	Cellular Physiology	2	2	76

J.‐P. Magaud

Publications

909

Citations

H-Index

Page 1

	Year	Citations
A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki‐1 lymphoma') Ruth Rimokh, J.‐P. Magaud, Françoise Berger, British Journal of Haematology Tumor BiologyLymphoid NeoplasiaCytogeneticsMalignant Blood DisorderHistopathology	1989	245
Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake J.‐P. Magaud, Ian L. Sargent, David Y. Mason Journal of Immunological Methods Immunoenzymatic MeasurementBromodeoxyuridine UptakeAllergyImmunotoxicologyBioanalysis	1988	150
Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine. J.‐P. Magaud, Ian L. Sargent, P J Clarke, Journal of Histochemistry & Cytochemistry Immunocytochemical TechniqueLaboratory ImmunologyImmunologyPathologyImmunophenotyping	1989	95
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). Bertrand Coiffier, P.A. Bryon, F Berger, Journal of Clinical Oncology PathologyPharmacotherapyMetronomic ChemotherapyImmunotherapyHematological Malignancy	1986	71
T-cell lymphomas: immunologic, histologic, clinical, and therapeutic analysis of 63 cases. Bertrand Coiffier, F Berger, P.A. Bryon, Journal of Clinical Oncology Therapeutic AnalysisImmunologyClinical PresentationPathologyImmunotherapy	1988	69
Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Denis Guyotat, Lydia Campos, Zhihua Shi, PubMed	1990	62
CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Xavier Thomas, E Archimbaud, C Charrin, PubMed	1995	53
During hematopoiesis, expression of FLRG, a novel activin A ligand, is regulated by TGF-β Véronique Maguer‐Satta, Laurent Bartholin, Sandrine Jeanpierre, Experimental Hematology Developmental BiologyImmunologyHematologyHeme SignalingBlood Cell	2001	48
Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells. Karine Vidal, C Samarut, J.‐P. Magaud, The Journal of Immunology	1993	46
Identification of functional domains involved in BTG1 cell localization Anne Rodier, Pierrick Rochard, Cyril Berthet, Oncogene Btg1 Cell LocalizationSignal TransductionCell RegulationCell InteractionCellular Biochemistry	2001	28

Page 1